Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth is an equity fund. This fund was started on 26 October, 2020. The fund is managed by Bhavesh Jain. The fund could potentially beat inflation in the long-run.

1. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has ₹160 Cr worth of assets under management (AUM) as on Mar 2025 and is less than category average.
2. The fund has an expense ratio 0.5.
   

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has given a CAGR return of 15.42% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 10.79% and 17.88% respectively.

Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has allocated its funds majorly in Health, Cash Equivalent. Its top holdings are Sun Pharmaceuticals Industries Ltd, Max Healthcare Institute Ltd Ordinary Shares, Cipla Ltd, Eli Lilly and Co, Dr Reddy's Laboratories Ltd

As it is a index funds mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.

Minimum investment for lump sum payment is INR 100.00 and for SIP is INR 100.00. Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth has no lock in period.